Additionally, it was shown that acyclic nucleotide phosphonates inhibit Akt phosphorylation in the mammalian target of rapamycin pathway, leading to anti-HCC effects [28,30]. The gene discussed is AKT1; the disease is hepatocellular carcinoma.